Results 121 to 130 of about 16,707 (188)

Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity

open access: yes, 2007
Sialic acid-binding immunoglobulin-like lectins (siglecs) are predominately expressed on immune cells. They are best known as regulators of cell signaling mediated by cytoplasmic tyrosine motifs and are increasingly recognized as receptors for pathogens ...
Crocker, Paul R.   +6 more
core   +1 more source

Neisserial adhesin A (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion/invasion [PDF]

open access: yes
Neisserial adhesin A (NadA) is a meningococcal surface protein included as recombinant antigen in 4CMenB, a protein-based vaccine able to induce protective immune responses against Neisseria meningitidis serogroup B (MenB).
Perrotta, A   +37 more
core   +1 more source

Identification, characterization, and mapping of novel members of the Siglec family [PDF]

open access: yes, 2001
grantor: University of TorontoThe sialic acid binding immunoglobulin-like lectin (Siglec) family is a recently described member of the immunoglobulin superfamily.
Foussias, George
core  

Siglec‐1, an easy and contributory inflammation marker in rheumatology

open access: yesClinical & Translational Immunology
Objectives Inflammatory markers such as erythrocyte sedimentation rate (ESR) and C‐reactive protein (CRP) are poorly informative about interferon (IFN)‐related disorders.
Valentina Boz   +10 more
doaj   +1 more source

Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia

open access: yesNature Communications
Siglec-6 is a lectin receptor with restricted expression in the placenta, mast cells and memory B-cells. Although Siglec-6 is expressed in patients with chronic lymphocytic leukemia (CLL), its pathophysiological role has not been elucidated.
Jessica Nunes   +9 more
doaj   +1 more source

Optimizing Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders

open access: yes
Background/Objective: Current treatments for eosinophilic and mast cell disorders are often ineffective. One promising target to improve outcomes is sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8).
Junyang Li   +21 more
core   +1 more source

Sialic acid <i>cis</i>-ligands as modulators of Siglec function in cancer immunity. [PDF]

open access: yesOncoimmunology
Valk AHC   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy